Trends of norfloxacin and erythromycin resistance of Campylobacter jejuni/Campylobacter coli isolates recovered from international travelers, 1994 to 2006

Journal of Travel Medicine

Volumn 15, Issue 6, 2008, Pages 419-425

  Vlieghe, Erika R ^a   Jacobs, Jan A ^a   Van Esbroeck, Marjan ^a   Koole, Olivier ^a   Van Gompel, Alfons ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; NORFLOXACIN;

AFRICA; ANTIBIOTIC RESISTANCE; ARTICLE; ASIA; BELGIUM; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; DRUG SENSITIVITY; FECES ANALYSIS; HUMAN; INDIA; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; RETROSPECTIVE STUDY; SOUTH AND CENTRAL AMERICA; TRAVEL; TRAVELLER DIARRHEA;

ANTI-BACTERIAL AGENTS; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; DIARRHEA; DRUG RESISTANCE, BACTERIAL; ENTEROCOLITIS; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; NORFLOXACIN; TRAVEL;

EID: 56849117901     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2008.00236.x     Document Type: Article

References (40)

1. Ruiz-Palacios GM. The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken. Clin Infect Dis 2007 44 : 701 703.
2. Smith KE, Besser JM, Hedberg CW, et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. N Engl J Med 1999 340 : 1525 1532.
3. Sjogren E, Lindblom GB, Kaijser B. Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients. J Antimicrob Chemother 1997 40 : 257 261.
4. Ekdahl K, Andersson Y. Regional risks and seasonality in travel-associated campylobacteriosis. BMC Infect Dis 2004 4 : 54.
5. Coker AO, Isokpehi RD, Thomas BN, et al. Human campylobacteriosis in developing countries. Emerg Infect Dis 2002 8 : 237 244.
6. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001 32 : 331 351.
7. Murphy GS Jr., Echeverria P, Jackson LR, et al. Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994. Clin Infect Dis 1996 22 : 868 869.
8. Hoge CW, Gambel JM, Srijan A, et al. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis 1998 26 : 341 345.
9. Engberg J, Aarestrup FM, Taylor DE, et al. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis 2001 7 : 24 34.
10. Hakanen A, Jousimies-Somer H, Siitonen A, et al. Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination. Emerg Infect Dis 2003 9 : 267 270.
11. Isenbarger DW, Hoge CW, Srijan A, et al. Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999. Emerg Infect Dis 2002 8 : 175 180.
12. Unicomb L, Ferguson J, Riley TV, Collignon P. Fluoroquinolone resistance in Campylobacter absent from isolates, Australia. Emerg Infect Dis 2003 9 : 1482 1483.
13. McDermott PF, Bodeis-Jones SM, Fritsche TR, et al. Broth microdilution susceptibility testing of Campylobacter jejuni and the determination of quality control ranges for fourteen antimicrobial agents. J Clin Microbiol 2005 43 : 6136 6138.
14. Chu YW, Chu MY, Luey KY, et al. Genetic relatedness and quinolone resistance of Campylobacter jejuni strains isolated in 2002 in Hong Kong. J Clin Microbiol 2004 42 : 3321 3323.
15. Nachamkin I, Ung H, Li M. Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA, 1982-2001. Emerg Infect Dis 2002 8 : 1501 1503.
16. Osterlund A, Hermann M, Kahlmeter G. Antibiotic resistance among Campylobacter jejuni/coli strains acquired in Sweden and abroad: a longitudinal study. Scand J Infect Dis 2003 35 : 478 481.
17. Nelson JM, Smith KE, Vugia DJ, et al. Prolonged diarrhea due to ciprofloxacin-resistant campylobacter infection. J Infect Dis 2004 190 : 1150 1157.
18. Ruiz J, Marco F, Oliveira I, et al. Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea. APMIS 2007 115 : 218 224.
19. Gaudreau C, Gilbert H. Antimicrobial resistance of Campylobacter jejuni subsp. jejuni strains isolated from humans in 1998 to 2001 in Montreal, Canada. Antimicrob Agents Chemother 2003 47 : 2027 2029.
20. Schonberg-Norio D, Hanninen ML, Katila ML, et al. Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects. Antimicrob Agents Chemother 2006 50 : 1086 1088.
21. Luangtongkum T, Morishita TY, El Tayeb AB, et al. Comparison of antimicrobial susceptibility testing of Campylobacter spp. by the agar dilution and the agar disk diffusion methods. J Clin Microbiol 2007 45 : 590 594.
22. Lehtopolku M, Hakanen AJ, Siitonen A, et al. In vitro activities of 11 fluoroquinolones against 226 Campylobacter jejuni strains isolated from Finnish patients, with special reference to ciprofloxacin resistance. J Antimicrob Chemother 2005 56 : 1134 1138.
23. Hakanen AJ, Lehtopolku M, Siitonen A, et al. Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995-2000. J Antimicrob Chemother 2003 52 : 1035 1039.
24. Sanders JW, Isenbarger DW, Walz SE, et al. An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection. Am J Trop Med Hyg 2002 67 : 533 538.
25. Papavasileiou E, Voyatzi A, Papavasileiou K, et al. Antimicrobial susceptibilities of Campylobacter jejuni isolates from hospitalized children in Athens, Greece, collected during 2004-2005. Eur J Epidemiol 2007 22 : 77 78.
26. Putnam SD, Frenck RW, Riddle MS, et al. Antimicrobial susceptibility trends in Campylobacter jejuni and Campylobacter coli isolated from a rural Egyptian pediatric population with diarrhea. Diagn Microbiol Infect Dis 2003 47 : 601 608.
27. Sonnevend A, Rotimi VO, Kolodziejek J, et al. High level of ciprofloxacin resistance and its molecular background among Campylobacter jejuni strains isolated in the United Arab Emirates. J Med Microbiol 2006 55 : 1533 1538.
28. Prasad KN, Mathur SK, Dhole TN, Ayyagari A. Antimicrobial susceptibility and plasmid analysis of Campylobacter jejuni isolated from diarrhoeal patients and healthy chickens in northern India. J Diarrhoeal Dis Res 1994 12 : 270 273.
29. Jain D, Sinha S, Prasad KN, Pandey CM. Campylobacter species and drug resistance in a north Indian rural community. Trans R Soc Trop Med Hyg 2005 99 : 207 214.
30. Cardinale E, Dromigny JA, Tall F, et al. Fluoroquinolone susceptibility of Campylobacter strains, Senegal. Emerg Infect Dis 2003 9 : 1479 1481.
31. Fernandez H, Mansilla M, Gonzalez V. Antimicrobial susceptibility of Campylobacter jejuni subsp. jejuni assessed by E-test and double dilution agar method in Southern Chile. Mem Inst Oswaldo Cruz 2000 95 : 247 249.
32. Van Looveren M, Daube G, De Zutter L, et al. Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium. J Antimicrob Chemother 2001 48 : 235 240.
33. Wagner J, Jabbusch M, Eisenblatter M, et al. Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline. Antimicrob Agents Chemother 2003 47 : 2358 2361.
34. Gibreel A, Taylor DE. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 2006 58 : 243 255.
35. Coker AO, Adefeso AO. The changing patterns of Campylobacter jejuni/coli in Lagos, Nigeria after ten years. East Afr Med J 1994 71 : 437 440.
36. Altekruse SF, Stern NJ, Fields PI, Swerdlow DL. Campylobacter jejuni - an emerging foodborne pathogen. Emerg Infect Dis 1999 5 : 28 35.
37. Hill DR, Ericsson CD, Pearson RD, et al. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006 43 : 1499 1539.
38. Silley P. Campylobacter and fluoroquinolones: a bias data set? Environ Microbiol 2003 5 : 219 230.
39. DuPont HL. Azithromycin for the self-treatment of traveler's diarrhea. Clin Infect Dis 2007 44 : 347 349.
40. Ternhag A, Asikainen T, Giesecke J, Ekdahl K. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin Infect Dis 2007 44 : 696 700.